Current role
Biotechnology · Healthcare
CEO, Board Member
2020-06-02–present
Carole S. Ben-Maimon
Board Member
Larimar Therapeutics, Inc. (LRMR)Equibles does not estimate personal net worth.
Get an email with a short summary when Larimar Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LRMR alertsAbout Carole S. Ben-Maimon
Carole S. Ben-Maimon is recorded as Board Member at Larimar Therapeutics, Inc. (LRMR) since June 2, 2020 and CEO at Larimar Therapeutics, Inc. (LRMR). The newest filing on record that lists Carole S. Ben-Maimon as CEO at Larimar Therapeutics, Inc. (LRMR) is dated April 20, 2026. The proxy statement of Larimar Therapeutics, Inc. reports total compensation of $3,526,423 for Carole S. Ben-Maimon in fiscal 2025, including a base salary of $650,000. Disclosed compensation is on record for 6 fiscal years. Larimar Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Larimar Therapeutics, Inc. includes Carole Ben-Maimon (CEO and Board Member), Joseph Truitt (Chairman and Board Member), Michael Celano (CFO) and 7 others.
Affiliation history
-
Current
2020-06-02–present
-
Current
Start not stated–present
Last confirmed April 20, 2026
Company network
Leadership on record at Larimar Therapeutics, Inc.
- Carole Ben-Maimon CEO, Board Member
- Joseph Truitt Chairman, Board Member
- Michael Celano CFO
- John B. Harlow, Jr. COO
- Frank E. Thomas Board Member
- Jeffrey W. Sherman, MD, FACP Board Member
- Jonathan Leff Board Member
- Thomas E. Hamilton Board Member
- Thomas Edward Hamilton Board Member
- Thomas O. Daniel Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $650,000 | $3,526,423 |
| 2024 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $600,000 | $2,511,649 |
| 2023 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $560,000 | $3,137,431 |
| 2022 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $527,850 | $2,129,549 |
| 2021 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $510,000 | $2,233,823 |
| 2020 | Larimar Therapeutics, Inc. (LRMR) | President and Chief Executive Officer | $267,626 | $5,270,178 |
Recent activity
No call appearances or filed executive changes recorded yet.